IV therapy & vitamin injections — what the evidence actually supports
Medically reviewed by
The LovMedSpa medical team, led by Dr. Ahmed Elsoury, MD and Dr. Mark Ennett, MD
Last reviewed: June 2026
IV hydration and targeted nutrient injections have a defined set of well-supported clinical applications — and a broader set of wellness claims that the current evidence does not robustly back. The delivery mechanism is real: IV administration bypasses gastrointestinal absorption variability and delivers nutrients directly into circulation. B12 injection is the strongest evidence-supported application — patients with confirmed deficiency, pernicious anemia, or impaired intrinsic factor production have a documented clinical need that oral supplementation often cannot adequately address. IV hydration for genuine dehydration and post-exertion recovery is similarly supported. General wellness claims — "energy boost," "immune support," "anti-aging" — are weakly supported by the current literature in patients without an underlying deficiency, and a provider who presents these as established is overstating what the evidence shows. That honesty is the starting point for making a genuinely informed decision about these treatments.
What IV delivery does differently — and when that advantage is real
The pharmacokinetic argument for IV over oral delivery is legitimate in specific contexts. Oral vitamin B12 absorption depends on intrinsic factor — a glycoprotein secreted by the stomach's parietal cells — for uptake in the terminal ileum. In patients with pernicious anemia (autoimmune destruction of parietal cells), atrophic gastritis, celiac disease affecting the ileum, or a history of gastric bypass or ileal resection, oral B12 at any dose achieves poor absorption because the transport mechanism is compromised. Intramuscular or IV B12 bypasses this entirely — it is delivered directly into circulation and does not depend on a functional GI absorption pathway. For deficiency driven by absorption impairment rather than dietary inadequacy, injection is not a wellness upgrade over oral supplementation; it is the appropriate clinical modality. IV rehydration also has a genuine pharmacokinetic rationale: fluids administered intravenously enter the bloodstream immediately, while oral intake requires gastric emptying and intestinal absorption — a meaningful speed difference in acute dehydration, post-event recovery, or illness-related fluid loss where rapid repletion is the goal. Outside these contexts, the delivery advantage is less clear. Water-soluble vitamins — vitamin C and the B-complex — are renally excreted when present above physiologic levels; a well-nourished, non-deficient patient receiving IV B-vitamins will excrete the excess in urine. The mechanism that makes IV delivery advantageous in deficiency states (bypassing absorption) is not an advantage when absorption is not the limiting factor.
Where the evidence is strong, and where it is not
The evidence for IV nutrient therapy is not uniform across indications, and treating all claims as equivalent misrepresents a genuinely varied literature. B12 injection for confirmed deficiency or absorption impairment: well-established, with decades of clinical evidence and clear mechanistic support. IV hydration with electrolytes for acute dehydration and recovery: supported, with a straightforward physiological rationale. The Myers' Cocktail — a formulation of magnesium, B-vitamins, vitamin C, and calcium — has patient satisfaction data and small case series supporting its use in fibromyalgia and some fatigue states, but lacks rigorous randomized controlled trial evidence for general wellness indications. High-dose IV vitamin C has an emerging research base in specific oncology support contexts — but this is an active clinical research area, not an established standard of care, and should not be generalized to general immune support claims. NAD+ (nicotinamide adenine dinucleotide) IV therapy is mechanistically interesting — NAD+ is a coenzyme central to cellular energy metabolism and DNA repair, and levels decline with age — but large-scale, randomized human clinical trial data on IV dosing for wellness indications is preliminary. General claims of energy enhancement, immune boosting, or anti-aging benefit from IV vitamins in non-deficient, otherwise healthy patients are not supported by the current controlled trial literature. The honest framing is that some patients report feeling better after IV therapy, the placebo effect in wellness settings is well-documented and non-trivial, and the risk profile of IV vitamins in appropriately screened patients is low — but these are distinct observations from a claim of established clinical efficacy.
Candidacy screening — why the clinical setting is the real differentiator
IV therapy administered without a pre-treatment health screening is not the same procedure as IV therapy administered in a medically supervised setting, regardless of the formulation. The screening matters for specific clinical reasons. Renal impairment changes how the body handles water-soluble vitamin loads — kidneys with compromised filtration cannot excrete excess safely, and high-dose IV vitamins in patients with renal insufficiency carry a different risk profile than in patients with normal function. Cardiac conditions — particularly congestive heart failure or certain arrhythmias — require assessment before any IV fluid load, because additional circulating volume stresses an already-compromised cardiac system. G6PD deficiency (glucose-6-phosphate dehydrogenase deficiency) is a specific contraindication for high-dose IV vitamin C: the enzyme deficiency means high-dose ascorbate can trigger hemolytic anemia, a rare but serious reaction with no reliable advance warning absent screening. Ingredient and preservative allergies require review before IV administration. A health intake that catches these contraindications is not a formality — it is what separates a clinical IV practice from a retail one. IV therapy is also not a substitute for primary medical care: persistent fatigue, suspected nutrient deficiency, or systemic symptoms warrant evaluation by a primary care physician who can order the appropriate labs and determine the actual cause — not a drip based on symptom pattern alone.
Common questions
Does IV therapy actually give you more energy?
If fatigue is driven by B12 deficiency or genuine dehydration, IV therapy can produce measurable improvement — because it addresses the actual cause. If fatigue is not driven by a nutrient deficit or fluid loss, IV B-vitamins in a non-deficient patient are unlikely to produce benefit above placebo; the perception of increased energy after an IV drip in a well-nourished patient is not well-supported in placebo-controlled research. An honest provider will ask about deficiency history and likely causes of fatigue before recommending a specific formulation.
How is a B12 injection different from an oral B12 supplement?
Oral B12 absorption requires intrinsic factor — a glycoprotein secreted by the stomach's parietal cells — for uptake in the terminal ileum. Patients with pernicious anemia, atrophic gastritis, celiac disease affecting the ileum, or a history of gastric bypass may have significantly impaired oral absorption regardless of dose. Intramuscular or IV B12 bypasses this pathway entirely. For patients without absorption impairment, high-dose oral B12 (1,000–2,000 mcg daily) achieves adequate serum levels through passive diffusion; injection offers less marginal advantage in this group.
Is IV therapy safe?
IV therapy administered in a clinically supervised setting — with a pre-treatment health intake, appropriate ingredient and allergy screening, vital signs assessment, and an IV line placed by trained clinical staff — is generally well-tolerated. Risks are real but low with proper screening: local reactions at the IV site, rare electrolyte imbalance from large fluid volumes, and allergy to formulation components. The safety distinction is between a setting that screens candidates appropriately and one that does not. The procedure is lower-risk when patient selection is clinically reviewed.
At LovMedSpa, IV therapy and vitamin injections are administered following a pre-treatment health intake and candidacy review, under the oversight of medical director Dr. Ahmed Elsoury, MD (New York and Connecticut) and Dr. Mark Ennett, MD (South Florida), across our Brooklyn, Manhattan, Staten Island, Aventura, and West Farms locations. A consultation is the right place to discuss your specific health history, goals, and whether IV therapy is an appropriate fit.
This is general information, not medical advice. IV therapy and vitamin injections are not substitutes for primary medical care. Persistent fatigue, suspected nutrient deficiency, or systemic symptoms should be evaluated by a primary care physician. Candidacy is determined by a licensed provider at consultation based on individual health history.